20 states excel at protecting the vulnerable from COVID-19

Dave Pearson | | Health Exec | Management
Covid Map

Using such metrics as pledges of free vaccine when one becomes available, adoption of telemedicine and per-capita COVID relief monies, WalletHub has ranked all the states plus the District of Columbia in order of most to least supportive of at-risk populations during the pandemic.

Here’s a countdown of the 20 best at that task in the eyes of the popular personal-finance website:

20.  Louisiana

19.  New Jersey

18.  Nevada

17.  Connecticut

16.  Wyoming

15.  Oregon

14.  Hawaii

13.  Washington

12.  New York

11.  Maryland

10.  Minnesota

9.  Kentucky

8.  Colorado

7.  Vermont

6.  New Mexico

5.  North Dakota

4.  Maine

3.  Rhode Island

2.  District of Columbia

1.  Massachusetts

For the full rankings, explanations of the metrics and the rest of the reporting, click here.

Dave Pearson
Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Related Content

Q&A: Proposed changes to Social Security Act would recognize pharmacists as healthcare providers
FDA issues Class I recall on counterfeit infusion pump batteries
FDA issues alert on PCNL sheath safety after patient death
Bipartisan bills in Congress would force insurance companies, PBMs to sell pharmacies
Anthem BCBS reverses course on anesthesia time limits
FDA issues Class I recall on insulin syringes due to risk of death

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.